Intervention Protocol

You have free access to this content

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants

  1. Kiran More1,*,
  2. Gayatri Athalye-Jape1,
  3. Shripada C Rao2,
  4. Sanjay K Patole3

Editorial Group: Cochrane Neonatal Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 2 MAR 2013

DOI: 10.1002/14651858.CD010531


How to Cite

More K, Athalye-Jape G, Rao SC, Patole SK. Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010531. DOI: 10.1002/14651858.CD010531.

Author Information

  1. 1

    Princess Margaret Hospital and King Edward Hospital, Department of Neonatology, Subiaco, Western Australia, Australia

  2. 2

    King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children, Centre for Neonatal Research and Education, Perth, Western Australia, Australia

  3. 3

    King Edward Memorial Hospital, School of Paediatrics and Child Health, School of Women's and Infant's Health, University of Western Australia, Perth, Western Australia, Australia

*Kiran More, Department of Neonatology, Princess Margaret Hospital and King Edward Hospital, Roberts Road, Subiaco, Western Australia, 6008, Australia. drkiranmore@yahoo.com. kiran.more@health.wa.gov.au.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To assess the efficacy and safety of ETRA in the treatment of PPHN in full-term and late preterm infants.
  2. To assess the efficacy and safety of selective (which block only the ETA receptors) and non-selective (which block both ETA and ETB receptors) ETRA separately.